cardioКардиологияKardiologiia0022-90402412-5660Kardiomag10.18087/cardio.2024.4.n2525cardio-2525Research ArticleОБЗОРЫREVIEWSОсобенности артериальной гипертензии в эру пандемии COVID-19: общность патогенетических звеньев АГ и SARS-CoV-2Features of the Course of Arterial Hypertension in the Era of the COVID-19 Pandemic: Common Pathogenetic Links Between Hypertension and SARS-CoV-2https://orcid.org/0000-0003-1002-1895БернсС. А.BernsS. A.

д.м.н., профессор кафедры терапии и общей врачебной практики, руководитель отдела изучения патогенетических аспектов старения 

Москва, Россия

Dr. Sci. (Med.), Рrofessor at the Department of Therapy and General Medical Practice, Head of the Department for the Study of Pathogenetic Aspects of Aging at the National Medical Research Center for therapy and Preventive Medicine,

Moscow, Russia

svberns@yandex.ruhttps://orcid.org/0000-0001-8138-4939ЛеонтьеваМ. С.LeontyevaM. S.

врач-терапевт, заведующая терапевтическим отделением

Москва, Россия

general practitioner, head of therapy department, GBUZ «City Clinical Hospital. F.I. Inozemtsev DZM», 

Moscow, Russia

mariy_masha@mail.ruhttps://orcid.org/0000-0002-6796-212XТавлуеваЕ. В.TavluevaE. V.

1профессор кафедры кардиологии, в.н.с. отдела изучения патогенетических аспектов старения, д.м.н., 2руководитель Регионального сосудистого центра

Москва, Россия

Dr. Sci. (Med.), Head of the Regional Vascular Center GBUZ «City Clinical Hospital. F.I. Inozemtsev DZM», Рrofessor at the Department of Cardiology, leading researcher of the Department for the Study of Pathogenetic Aspects of Aging at the National Medical Research Center for therapy and Preventive Medicine, 

Moscow, Russia

tavlev1@mail.ruhttps://orcid.org/0000-0001-9378-9378БашнякВ. С.BashnyakV. S.

врач-кардиолог, аспирант, лаборант исследователь отдела изучения патогенетических аспектов старения 

Москва, Россия

MD, Cardiologist, Postgraduate Student, laboratory assistant researcher of the Department for the Study of Pathogenetic Aspects of Aging at the National Medical Research Center for Therapy and Preventive Medicine

Moscow, Russia

VBashnyak@gnicpm.ruhttps://orcid.org/0000-0002-4453-8430ДрапкинаО. М.DrapkinaO. M.

доктор медицинских наук, профессор, академик РАН, директор

Москва, Россия

Dr. Sci. (Med.), Рrof., Academician of the Russian Academy of Sciences, Chief Internal Medicine and General Practice Specialist of the Ministry of Health of the Russian Federation, Head of National Medical Research Center for therapy and Preventive Medicine,

Moscow, Russia

drapkina@bk.ruФГБУ «Национальный медицинский исследовательский центр терапии и профилактической медицины» Минздрава РФРоссияNational Medical Research Center of Therapy and Preventive MedicineRussian FederationГБУЗ «Городская клиническая больница им. Ф.И. Иноземцева Департамента здравоохранения города Москвы»РоссияInozemtsev Municipal Clinical HospitalRussian FederationФГБУ «Национальный медицинский исследовательский центр терапии и профилактической медицины» Минздрава РФ; ГБУЗ «Городская клиническая больница им. Ф.И. Иноземцева Департамента здравоохранения города Москвы»РоссияNational Medical Research Center of Therapy and Preventive Medicine; Inozemtsev Municipal Clinical HospitalRussian Federation2024300420246447278Copyright © Kardiomag, 20242024KardiomagKardiomaghttps://cardio.elpub.ru/jour/about/submissions#copyrightNoticehttps://cardio.elpub.ru/jour/article/view/2525

Цель данного обзора – отразить механизм заражения Severe acute respiratory syndrome-related coronavirus-2 (SARS-CoV-2) и его возможное влияние на течение артериальной гипертензии. Кроме того, оценить взаимосвязь ренин-ангиотензин-альдостероновой системы с патогенетическими звеньями инфекции, вызванной вирусом SARS-CoV-2.

The aim of this review was to present the mechanism of infection with severe acute respiratory syndrome-related coronavirus-2 (SARS-CoV-2) and its possible effect on the course of arterial hypertension. Another aim was to evaluate the relationship of the renin-angiotensin-aldosterone system with the pathogenetic stages of infection caused by SARS-CoV-2 virus.

Артериальная гипертензиякоронавирусная инфекцияCOVID-19РААСАПФ2Arterial hypertensioncoronavirus infectionCOVID-19RAASACE2Конфликт интересов не заявленNo conflict of interest is reported.ReferencesWorld Health Organization. Coronavirus disease (COVID-19) pandemic. [Internet] Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019World Health Organization. Coronavirus disease (COVID-19) pandemic. [Internet] Available at: https://www.who.int/emergencies/diseases/novel-coronavirus-2019World Health Organization. WHO Coronavirus (COVID-19) Dashboard. [Internet] Available at: https://covid19.who.intWorld Health Organization. WHO Coronavirus (COVID-19) Dashboard. [Internet] Available at: https://covid19.who.intОрганизация Объединенных наций. ВОЗ: 1,28 млрд человек страдают гипертонией, больше половины из них не проходят лечение. [Internet] 2021. Available at: https://news.un.org/ru/story/2021/08/1408782United Nations. WHO: 1.28 billion people suffer from hypertension, more than half of them are not receiving treatment. [Internet] 2021. Available at: https://news.un.org/ru/story/2021/08/1408782Xu K, Cai H, Shen Y, Ni Q, Chen Y, Hu S et al. Management of COVID-19: the Zhejiang experience. Zhejiang Da Xue Xue Bao. Yi Xue Ban. 2020;49(2):147–57. DOI: 10.3785/j.issn.1008-9292.2020.02.02Xu K, Cai H, Shen Y, Ni Q, Chen Y, Hu S et al. Management of COVID-19: the Zhejiang experience. Zhejiang Da Xue Xue Bao. Yi Xue Ban. 2020;49(2):147–57. DOI: 10.3785/j.issn.1008-9292.2020.02.02Böger B, Fachi MM, Vilhena RO, Cobre AF, Tonin FS, Pontarolo R. Systematic review with meta-analysis of the accuracy of diagnostic tests for COVID-19. American Journal of Infection Control. 2021;49(1):21–9. DOI: 10.1016/j.ajic.2020.07.011Böger B, Fachi MM, Vilhena RO, Cobre AF, Tonin FS, Pontarolo R. Systematic review with meta-analysis of the accuracy of diagnostic tests for COVID-19. American Journal of Infection Control. 2021;49(1):21–9. DOI: 10.1016/j.ajic.2020.07.011Иванников А.А., Эсауленко А.Н., Васильченко М.К., Алиджанова Х.Г., Петриков С.С. COVID-19 и сердечно-сосудистая система. Часть II. Постковидный синдром. Журнал им. Н.В. Склифосовского «Неотложная медицинская помощь». 2021;10(2):248-58. DOI: 10.23934/2223-9022-2021-10-2-248-258Ivannikov A.A., Esaulenko A.N., Vasilchenko M.K., Alidzhanova Kh.G., Petrikov S.S. COVID-19 and Cardiovascular System. Part II. Post-COVID Syndrome. Russian Sklifosovsky Journal “Emergency Medical Care”. 2021;10(2):248–58. DOI: 10.23934/2223-9022-2021-10-2-248-258Золотовская И.А., Гиматдинова Г.Р., Давыдкин И.Л. Артериальная гипертензия у пациентов, перенесших COVID-19: особенности и возможности коррекции артериального давления. Профилактическая медицина. 2022;25(1):63–70. DOI: 10.17116/profmed20222501163Zolotovskaya I.A., Gimatdinova G.R., Davydkin I.L. Arterial hypertension in patients who have undergone COVID-19: features and possibilities of blood pressure correction. Prevention Medicine. 2022;25(1):63–70. DOI: 10.17116/profmed20222501163Кобалава Ж.Д., Конради А.О., Недогода С.В., Шляхто Е.В., Арутюнов Г.П., Баранова Е.И. и др. Артериальная гипертензия у взрослых. Клинические рекомендации 2020. Российский кардиологический журнал. 2020;25(3):149-218. DOI: 10.15829/1560-4071-2020-3-3786Kobalava Zh.D., Konradi A.O., Nedogoda S.V., Shlyakhto E.V., Arutyunov G.P., Baranova E.I. et al. Arterial hypertension in adults. Clinical guidelines 2020. Russian Journal of Cardiology. 2020;25(3):149–218. DOI: 10.15829/1560-4071-2020-3-3786Islam N, Lacey B, Shabnam S, Erzurumluoglu AM, Dambha-Miller H, Chowell G et al. Social inequality and the syndemic of chronic disease and COVID-19: county-level analysis in the USA. Journal of Epidemiology and Community Health. 2021;75(6):496–500. DOI: 10.1136/jech-2020-215626Islam N, Lacey B, Shabnam S, Erzurumluoglu AM, Dambha-Miller H, Chowell G et al. Social inequality and the syndemic of chronic disease and COVID-19: county-level analysis in the USA. Journal of Epidemiology and Community Health. 2021;75(6):496–500. DOI: 10.1136/jech-2020-215626Nishiga M, Wang DW, Han Y, Lewis DB, Wu JC. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nature Reviews Cardiology. 2020;17(9):543–58. DOI: 10.1038/s41569-020-0413-9Nishiga M, Wang DW, Han Y, Lewis DB, Wu JC. COVID-19 and cardiovascular disease: from basic mechanisms to clinical perspectives. Nature Reviews Cardiology. 2020;17(9):543–58. DOI: 10.1038/s41569-020-0413-9Libby P, Lüscher T. COVID-19 is, in the end, an endothelial disease. European Heart Journal. 2020;41(32):3038–44. DOI: 10.1093/eurheartj/ehaa623Libby P, Lüscher T. COVID-19 is, in the end, an endothelial disease. European Heart Journal. 2020;41(32):3038–44. DOI: 10.1093/eurheartj/ehaa623Guzik TJ, Mohiddin SA, Dimarco A, Patel V, Savvatis K, Marelli-Berg FM et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovascular Research. 2020;116(10):1666–87. DOI: 10.1093/cvr/cvaa106Guzik TJ, Mohiddin SA, Dimarco A, Patel V, Savvatis K, Marelli-Berg FM et al. COVID-19 and the cardiovascular system: implications for risk assessment, diagnosis, and treatment options. Cardiovascular Research. 2020;116(10):1666–87. DOI: 10.1093/cvr/cvaa106Загидуллин Н.Ш., Гареева Д.Ф., Ишметов В.Ш., Павлов А.В., Плотникова М.Р., Пушкарева А.Э. и др. Ренин-ангиотензиновая система при новой коронавирусной инфекции COVID-2019. Артериальная гипертензия. 2020;26(3):240–7. DOI: 10.18705/1607-419X-2020-26-3-240-247Zagidullin N.Sh., Gareeva D.F., Ishmetov V.Sh., Pavlov A.V., Plotnikova M.R., Pushkareva A.E. et al. Renin-angiotensin-aldosterone system in new coronavirus infection 2019. Arterial Hypertension. 2020;26(3):240–7. DOI: 10.18705/1607-419X-2020-26-3-240-247Петриков С.С., Тыров И.А., Перминов А.Ю., Фоменко Н.С. Организационно-информационная поддержка процессов лечения пациентов с COVID-19 в многопрофильном скоропомощном стационаре. Журнал им. Н.В. Склифосовского «Неотложная медицинская помощь». 2020;9(3):308-13. DOI: 10.23934/2223-9022-2020-9-3-308-313Petrikov S.S., Tyrov I.A., Perminov A.Yu., Fomenko N.S. Organizational and Informational Support for the Treatment of Patients With COVID-19 in a Multidisciplinary Emergency Hospital. Russian Sklifosovsky Journal “Emergency Medical Care”. 2020;9(3):308–13. DOI: 10.23934/2223-9022-2020-9-3-308-313Sardu C, Gambardella J, Morelli MB, Wang X, Marfella R, Santulli G. Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence. Journal of Clinical Medicine. 2020;9(5):1417. DOI: 10.3390/jcm9051417Sardu C, Gambardella J, Morelli MB, Wang X, Marfella R, Santulli G. Hypertension, Thrombosis, Kidney Failure, and Diabetes: Is COVID-19 an Endothelial Disease? A Comprehensive Evaluation of Clinical and Basic Evidence. Journal of Clinical Medicine. 2020;9(5):1417. DOI: 10.3390/jcm9051417Escher R, Breakey N, Lämmle B. Severe COVID-19 infection associated with endothelial activation. Thrombosis Research. 2020;190:62. DOI: 10.1016/j.thromres.2020.04.014Escher R, Breakey N, Lämmle B. Severe COVID-19 infection associated with endothelial activation. Thrombosis Research. 2020;190:62. DOI: 10.1016/j.thromres.2020.04.014Schiffrin EL, Flack JM, Ito S, Muntner P, Webb RC. Hypertension and COVID-19. American Journal of Hypertension. 2020;33(5):373–4. DOI: 10.1093/ajh/hpaa057Schiffrin EL, Flack JM, Ito S, Muntner P, Webb RC. Hypertension and COVID-19. American Journal of Hypertension. 2020;33(5):373–4. DOI: 10.1093/ajh/hpaa057Chen T, Wu D, Chen H, Yan W, Yang D, Chen G et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368:m1091. DOI: 10.1136/bmj.m1091Chen T, Wu D, Chen H, Yan W, Yang D, Chen G et al. Clinical characteristics of 113 deceased patients with coronavirus disease 2019: retrospective study. BMJ. 2020;368:m1091. DOI: 10.1136/bmj.m1091Guan W, Liang W, Zhao Y, Liang H, Chen Z, Li Y et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. European Respiratory Journal. 2020;55(5):2000547. DOI: 10.1183/13993003.00547-2020Guan W, Liang W, Zhao Y, Liang H, Chen Z, Li Y et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. European Respiratory Journal. 2020;55(5):2000547. DOI: 10.1183/13993003.00547-2020Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. 2020;395(10229):1054–62. DOI: 10.1016/S0140-6736(20)30566-3Zhou F, Yu T, Du R, Fan G, Liu Y, Liu Z et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. The Lancet. 2020;395(10229):1054–62. DOI: 10.1016/S0140-6736(20)30566-3Durvasula R, Wellington T, McNamara E, Watnick S. COVID-19 and Kidney Failure in the Acute Care Setting: Our Experience From Seattle. American Journal of Kidney Diseases. 2020;76(1):4–6. DOI: 10.1053/j.ajkd.2020.04.001Durvasula R, Wellington T, McNamara E, Watnick S. COVID-19 and Kidney Failure in the Acute Care Setting: Our Experience From Seattle. American Journal of Kidney Diseases. 2020;76(1):4–6. DOI: 10.1053/j.ajkd.2020.04.001Ronco C, Reis T. Kidney involvement in COVID-19 and rationale for extracorporeal therapies. Nature Reviews Nephrology. 2020;16(6):308–10. DOI: 10.1038/s41581-020-0284-7Ronco C, Reis T. Kidney involvement in COVID-19 and rationale for extracorporeal therapies. Nature Reviews Nephrology. 2020;16(6):308–10. DOI: 10.1038/s41581-020-0284-7Mao L, Jin H, Wang M, Hu Y, Chen S, He Q et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurology. 2020;77(6):683–90. DOI: 10.1001/jamaneurol.2020.1127Mao L, Jin H, Wang M, Hu Y, Chen S, He Q et al. Neurologic Manifestations of Hospitalized Patients With Coronavirus Disease 2019 in Wuhan, China. JAMA Neurology. 2020;77(6):683–90. DOI: 10.1001/jamaneurol.2020.1127Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. The Lancet. 2020;395(10237):1607–8. DOI: 10.1016/S0140-6736(20)31094-1Riphagen S, Gomez X, Gonzalez-Martinez C, Wilkinson N, Theocharis P. Hyperinflammatory shock in children during COVID-19 pandemic. The Lancet. 2020;395(10237):1607–8. DOI: 10.1016/S0140-6736(20)31094-1Головкин А.С., Кудрявцев И.В., Дмитриев А.В., Калинина О.В. Фиброзные изменения сердечно-сосудистой и дыхательной систем после перенесенной covid-19: вклад факторов иммунной системы и генетическая предрасположенность. Российский кардиологический журнал. 2020;25(10):214-20. DOI: 10.15829/1560-4071-2020-4087Golovkin A.S., Kudryavtsev I.V., Dmitriev A.V., Kalinina O.V. Fibrosis in the cardiovascular and respiratory systems after covid-19: a contribution of immune factors and genetic predisposition. Russian Journal of Cardiology. 2020;25(10):214–20. DOI: 10.15829/1560-4071-2020-4087Ларина В.Н., Головко М.Г., Ларин В.Г. Влияние коронавирусной инфекции (COVID-19) на сердечно-сосудистую систему. Вестник Российского государственного медицинского университета. 2020;2:5-13. DOI: 10.24075/vrgmu.2020.020Larina V.N., Golovko M.G., Larin V.G. Possible Effects of Coronavirus Infection (COVID-19) on the Cardiovascular System. Bulletin of RSMU. 2020;2:5–13. DOI: 10.24075/vrgmu.2020.020Corman VM, Lienau J, Witzenrath M. Coronaviruses as the cause of respiratory infections. Der Internist. 2019;60(11):1136–45. DOI: 10.1007/s00108-019-00671-5Corman VM, Lienau J, Witzenrath M. Coronaviruses as the cause of respiratory infections. Der Internist. 2019;60(11):1136–45. DOI: 10.1007/s00108-019-00671-5Srivastava SP, Goodwin JE, Kanasaki K, Koya D. Inhibition of Angiotensin-Converting Enzyme Ameliorates Renal Fibrosis by Mitigating DPP-4 Level and Restoring Antifibrotic MicroRNAs. Genes. 2020;11(2):211. DOI: 10.3390/genes11020211Srivastava SP, Goodwin JE, Kanasaki K, Koya D. Inhibition of Angiotensin-Converting Enzyme Ameliorates Renal Fibrosis by Mitigating DPP-4 Level and Restoring Antifibrotic MicroRNAs. Genes. 2020;11(2):211. DOI: 10.3390/genes11020211Бубнова М.Г., Аронов Д.М. COVID-19 и сердечно-сосудистые заболевания: от эпидемиологии до реабилитации. Пульмонология. 2020;30(5):688–99. DOI: 10.18093/0869-0189-2020-30-5-688-699Bubnova M.G., Aronov D.M. COVID-19 and cardiovascular diseases: from epidemiology to rehabilitation. Pulmonologiya. 2020;30(5):688–99. DOI: 10.18093/0869-0189-2020-30-5-688-699Хегай Л.Н., Сайфуллаева С.А., Абдурахимов А.Х. Роль компонентов ренин-ангиотензин-альдостероновой системы в клинических проявлениях COVID-19. Re-health journal. 2021;1(9):220-8. DOI: 10.24411/2181-0443/2021-10038Xegay L.N., Sayfullaeva S.A., Abdurahimov A.Kh. The role of the components of the renin-angiotensin-aldosterone system in the clinical manifestations of COVID-19. Re-health journal. 2021;1(9):220–8. DOI: 10.24411/2181-0443/2021-10038Reynolds HR, Adhikari S, Pulgarin C, Troxel AB, Iturrate E, Johnson SB et al. Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19. New England Journal of Medicine. 2020;382(25):2441–8. DOI: 10.1056/NEJMoa2008975Reynolds HR, Adhikari S, Pulgarin C, Troxel AB, Iturrate E, Johnson SB et al. Renin–Angiotensin–Aldosterone System Inhibitors and Risk of Covid-19. New England Journal of Medicine. 2020;382(25):2441–8. DOI: 10.1056/NEJMoa2008975de Abajo FJ, Rodríguez-Martín S, Lerma V, Mejía-Abril G, Aguilar M, García-Luque A et al. Use of renin–angiotensin–aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study. The Lancet. 2020;395(10238):1705–14. DOI: 10.1016/S0140-6736(20)31030-8de Abajo FJ, Rodríguez-Martín S, Lerma V, Mejía-Abril G, Aguilar M, García-Luque A et al. Use of renin–angiotensin–aldosterone system inhibitors and risk of COVID-19 requiring admission to hospital: a case-population study. The Lancet. 2020;395(10238):1705–14. DOI: 10.1016/S0140-6736(20)31030-8Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TM-PRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181(2):271-280.e8. DOI: 10.1016/j.cell.2020.02.052Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S et al. SARS-CoV-2 Cell Entry Depends on ACE2 and TM-PRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell. 2020;181(2):271-280.e8. DOI: 10.1016/j.cell.2020.02.052Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh C-L, Abiona O et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367(6483):1260–3. DOI: 10.1126/science.abb2507Wrapp D, Wang N, Corbett KS, Goldsmith JA, Hsieh C-L, Abiona O et al. Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation. Science. 2020;367(6483):1260–3. DOI: 10.1126/science.abb2507Викулова О.К., Зураева З.Т., Никанкина Л.В., Шестакова М.В. Роль ренин-ангиотензиновой системы и ангиотензинпревращающего фермента 2 типа в развитии и течении вирусной инфекции СОVID-19 у пациентов с сахарным диабетом. Сахарный диабет. 2020:23(3)242-9. DOI: 10.14341/DM12501Vikulova O.K., Zuraeva Z.T., Nikankina L.V., Shestakova M.V. The role of renin-angiotensin system and angiotensin-converting enzyme 2 (ACE2) in the development and course of viral infection COVID-19 in patients with diabetes mellitus. Diabetes mellitus. 2020;23(3):242–9. DOI: 10.14341/DM12501Шляхто Е.В., Конради А.О., Арутюнов Г.П., Арутюнов А.Г., Баутин А.Е., Бойцов С.А. и др. Руководство по диагностике и лечению болезней системы кровообращения в контексте пандемии COVID-19. Российский кардиологический журнал. 2020;25(3):129-48. DOI: 10.15829/1560-4071-2020-3-3801Shlyakho E.V., Konradi A.O., Arutyunov G.P., Arutyunov A.G., Bautin A.E., Boytsov S.A. et al. Guidelines for the diagnosis and treatment of circulatory diseases in the context of the COVID-19 pandemic. Russian Journal of Cardiology. 2020;25(3):129–48. DOI: 10.15829/1560-4071-2020-3-3801Jessup JA, Brosnihan KB, Gallagher PE, Chappell MC, Ferrario CM. Differential effect of low-dose thiazides on the renin angiotensin system in genetically hypertensive and normotensive rats. Journal of the American Society of Hypertension. 2008;2(2):106–15. DOI: 10.1016/j.jash.2007.10.005Jessup JA, Brosnihan KB, Gallagher PE, Chappell MC, Ferrario CM. Differential effect of low-dose thiazides on the renin angiotensin system in genetically hypertensive and normotensive rats. Journal of the American Society of Hypertension. 2008;2(2):106–15. DOI: 10.1016/j.jash.2007.10.005Keidar S, Gamliel-Lazarovich A, Kaplan M, Pavlotzky E, Hamoud S, Hayek T et al. Mineralocorticoid Receptor Blocker Increases Angiotensin-Converting Enzyme 2 Activity in Congestive Heart Failure Patients. Circulation Research. 2005;97(9):946–53. DOI: 10.1161/01.RES.0000187500.24964.7AKeidar S, Gamliel-Lazarovich A, Kaplan M, Pavlotzky E, Hamoud S, Hayek T et al. Mineralocorticoid Receptor Blocker Increases Angiotensin-Converting Enzyme 2 Activity in Congestive Heart Failure Patients. Circulation Research. 2005;97(9):946–53. DOI: 10.1161/01.RES.0000187500.24964.7ACadegiani FA, Wambier CG, Goren A. Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19. Frontiers in Medicine. 2020;7:453. DOI: 10.3389/fmed.2020.00453Cadegiani FA, Wambier CG, Goren A. Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19. Frontiers in Medicine. 2020;7:453. DOI: 10.3389/fmed.2020.00453Villard O, Morquin D, Molinari N, Raingeard I, Nagot N, Cristol J-P et al. The Plasmatic Aldosterone and C-Reactive Protein Levels, and the Severity of Covid-19: The Dyhor-19 Study. Journal of Clinical Medicine. 2020;9(7):2315. DOI: 10.3390/jcm9072315Villard O, Morquin D, Molinari N, Raingeard I, Nagot N, Cristol J-P et al. The Plasmatic Aldosterone and C-Reactive Protein Levels, and the Severity of Covid-19: The Dyhor-19 Study. Journal of Clinical Medicine. 2020;9(7):2315. DOI: 10.3390/jcm9072315Kuba K, Imai Y, Penninger JM. Multiple Functions of Angiotensin-Converting Enzyme 2 and Its Relevance in Cardiovascular Diseases. Circulation Journal. 2013;77(2):301–8. DOI: 10.1253/circj.CJ-12-1544Kuba K, Imai Y, Penninger JM. Multiple Functions of Angiotensin-Converting Enzyme 2 and Its Relevance in Cardiovascular Diseases. Circulation Journal. 2013;77(2):301–8. DOI: 10.1253/circj.CJ-12-1544Канорский С.Г. Лечение артериальной гипертензии в период пандемии COVID-19: вопросы по поводу блокады ренин-ангиотензин-альдостероновой системы. Медицинский совет. 2021;4:59–67. DOI: 10.21518/2079-701X2021-4-59-67Kanorskiy S.G. Treatment of hypertension during the COVID-19 pandemic: questions about the blockade of the renin-angiotensin-aldosterone system. Medical Council. 2021;4:59–67. DOI: 10.21518/2079-701X2021-4-59-67Mancia G, Rea F, Ludergnani M, Apolone G, Corrao G. Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19. New England Journal of Medicine. 2020;382(25):2431–40. DOI: 10.1056/NEJMoa2006923Mancia G, Rea F, Ludergnani M, Apolone G, Corrao G. Renin–Angiotensin–Aldosterone System Blockers and the Risk of Covid-19. New England Journal of Medicine. 2020;382(25):2431–40. DOI: 10.1056/NEJMoa2006923Vaduganathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA, Solomon SD. Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19. New England Journal of Medicine. 2020;382(17):1653–9. DOI: 10.1056/NEJMsr2005760Vaduganathan M, Vardeny O, Michel T, McMurray JJV, Pfeffer MA, Solomon SD. Renin–Angiotensin–Aldosterone System Inhibitors in Patients with Covid-19. New England Journal of Medicine. 2020;382(17):1653–9. DOI: 10.1056/NEJMsr2005760Brojakowska A, Narula J, Shimony R, Bander J. Clinical Implications of SARS-CoV-2 Interaction With Renin Angiotensin System. Journal of the American College of Cardiology. 2020;75(24):3085–95. DOI: 10.1016/j.jacc.2020.04.028Brojakowska A, Narula J, Shimony R, Bander J. Clinical Implications of SARS-CoV-2 Interaction With Renin Angiotensin System. Journal of the American College of Cardiology. 2020;75(24):3085–95. DOI: 10.1016/j.jacc.2020.04.028

The authors declare that there are no conflicts of interest present.